Recombinant Human VEGFA Protein, His Tag
-
Product Number
KRP701
-
Alias
L VEGFA, MVCD1, Vascular permeability factor, VEGF
-
Specifications
- 100ug
- 500ug
- 1mg
KRP701
L VEGFA, MVCD1, Vascular permeability factor, VEGF
| Alias | L VEGFA, MVCD1, Vascular permeability factor, VEGF |
| Catalog Number | KRP701 |
| Product Introduction | Recombinant human vascular endothelial growth factor 165 is a core regulatory factor for angiogenesis and endothelial cell proliferation. Widely used in angiogenesis research, cardiovascular disease models, tissue engineering, and tumor angiogenesis experiments. |
| Molecular Name | VEGFA |
| Species | Human |
| Host | Sf9 Cells |
| Size | 100ug,500ug,1mg |
| Purity | >95%, determined by SDS-PAGE. |
| Concentration | Contact the sales manager to obtain the concentration of the latest batch. |
| Purification | Affinity Purification |
| Endotoxin | <0.1 EU/μg, determined by LAL method. |
| Background | A splice variant of vascular endothelial growth factor containing 165 amino acid residues, the most common and biologically active subtype of VEGF-A, and a key regulator of angiogenesis and vascular permeability. |
| Application | WB, ELISA |
| Predicted Molecular Weight | 19.2 kDa |
| Reconstitution | It is recommended that the lyophilized human VEGF 165 protein be dissolved in PBS at a concentration of 100 μg/ml for further dilution as the working concentration. |
| Storage Condition | Samples are stable for up to twelve months from date of receipt at -20℃ to -105℃. Avoid repeated freeze-thaw cycles. |
| Shipping Condition | This product is shipped on ice packs or dry ice. |
| Stability | Repeated freezing and thawing is not recommended. |
| Molecular Weight | 19-21 kDa |
| Uniprot ID | P15692 |
| References | 1. Leung, D.W. et al. (1989) Science 246:1306. 2. Keck, P.J. et al. (1989) Science 246:1309. 3. Byrne, A.M. et al. (2005) J. Cell. Mol. Med. 9:777. 4. Robinson, C.J. and S.E. Stringer (2001) J. Cell. Sci. 114:853. 5. Pan, Q. et al. (2007) J. Biol. Chem. 282:24049. 6. Weis, S.M. and D.A. Cheresh (2005) Nature 437:497. 7. Thurston, G. (2002) J. Anat. 200:575. 8. Carvalho, J.F. et al. (2007) J. Clin. Immunol. 27:246. 9. Angelo, L.S. and R. Kurzrock (2007) Clin. Cancer Res. 13:2825. |
| Function | Recombinant Human Vascular Endothelial Growth Factor 165 is the core regulatory factor for angiogenesis and endothelial cell proliferation. It is widely used in angiogenesis research, cardiovascular disease models, tissue engineering, and tumor vascularization experiments. |
| Product Declaration | This product is for research use only and must not be used directly on the human body or for injection. |
| Temperature Range | Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -45℃. Avoid repeated freeze-thaw cycles. |
| Product Full Name | Recombinant Human VEGF 165 Protein |
| Target | VEGF |
Vascular endothelial growth factor specifically and efficiently promotes the proliferation, migration, and lumen formation of vascular endothelial cells, being the core regulatory factor of vasculogenesis.
It is an essential inducer for the directed differentiation of pluripotent stem cells or hematopoietic stem cells into endothelial cells and vascular precursor cells; it is also used in organoid or tissue engineering constructs to induce vascular network formation.
0